Halozyme Therapeutics
HALO
#2477
Rank
$5.82 B
Marketcap
$45.76
Share price
2.12%
Change (1 day)
14.37%
Change (1 year)

P/S ratio for Halozyme Therapeutics (HALO)

P/S ratio as of November 2024 (TTM): 6.15

According to Halozyme Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 12.9. At the end of 2024 the company had a P/S ratio of 7.62.

P/S ratio history for Halozyme Therapeutics from 2005 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20247.6229.39%
20235.89-49.48%
202211.7-8.73%
202112.8-40.81%
202021.674.46%
201912.4-11.3%
201813.953.06%
20179.114.45%
20168.72-46.96%
201516.42.11%
201416.1-48.6%
201331.375.34%
201217.91.63%
201117.6-69.93%
201058.548.53%
200939.4-24.36%
200852.0-64.3%
2007146-74.13%
2006564-33.42%
2005847

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
7.64 24.31%๐Ÿ‡บ๐Ÿ‡ธ USA
17.5 184.81%๐Ÿ‡บ๐Ÿ‡ธ USA
1.11-81.92%๐Ÿ‡บ๐Ÿ‡ธ USA
2.54-58.67%๐Ÿ‡บ๐Ÿ‡ธ USA
2.26-63.16%๐Ÿ‡ซ๐Ÿ‡ท France
4.20-31.60%๐Ÿ‡บ๐Ÿ‡ธ USA